✦ LIBER ✦

S.28.04 Muscarinic agonists in the treatment of alzheimer's disease

✍ Scribed by Raj Kumar

Book ID: 118599738
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 297 KB
Volume: 7
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(97)88449-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Muscarinic agonists in Alzheimer's disea

Muscarinic agonists in Alzheimer's disease

✍ John H. Growdon 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 429 KB

Muscarinic agonists and antagonists in t

Muscarinic agonists and antagonists in the treatment of Alzheimer's disease

✍ W Greenlee; J Clader; T Asberom; S McCombie; J Ford; H Guzik; J Kozlowski; S Li; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 206 KB

The utility of muscarinic agonists in th

The utility of muscarinic agonists in the treatment of alzheimer’s disease

✍ William S. Messer 📂 Article 📅 2002 🏛 Humana Press Inc 🌐 English ⚖ 98 KB

S-14-2 - Muscarinic partial agonists in

S-14-2 - Muscarinic partial agonists in the symptomatic treatment of Alzheimer's Disease

✍ R. Kumar; E. Cedar; M. Clark; J. Loudon; J. McCafferty; L. Hammond 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 147 KB

ChemInform Abstract: Muscarinic Agonists

ChemInform Abstract: Muscarinic Agonists and Antagonists in the Treatment of Alzheimer′s Disease

✍ W. Greenlee; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 24 KB 👁 1 views

Xanomeline: A selective muscarinic agoni

Xanomeline: A selective muscarinic agonist for the treatment of Alzheimer's disease

✍ Frank P. Bymaster; Celia A. Whitesitt; Harlan E. Shannon; Neil DeLapp; John S. W 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB 👁 3 views

Xanomeline is a novel muscarinic receptor agonist relatively devoid of parasympathomimetic side effects. Xanomeline had high affinity for muscarinic receptors and much lower affinity for a variety of other neuronal receptors in radioligand binding assays. Functional studies in cell lines transfected